This page includes the latest FDA filings for Loxo Oncology Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
---|---|---|
Eli Lilly and Company, Loxo Oncology, Inc. | Prescription Medication | 2024-10-13 |
Eli Lilly and Company, Loxo Oncology, Inc. | Prescription Medication | 2024-10-11 |
Eli Lilly and Company, Loxo Oncology, Inc. | Prescription Medication | 2024-06-06 |
Eli Lilly and Company, Loxo Oncology, Inc. | Prescription Medication | 2024-04-20 |
Eli Lilly and Company, Loxo Oncology, Inc. | Prescription Medication | 2023-12-01 |
LOXO ONCOLOGY INC | 2023-02-03 22:03:41 | |
Eli Lilly and Company, Loxo Oncology, Inc. | Prescription Medication | 2022-10-04 |
Eli Lilly and Company, Loxo Oncology, Inc. | Prescription Medication | 2022-05-17 |
Eli Lilly and Company, Loxo Oncology, Inc. | Prescription Medication | 2021-02-12 |
Eli Lilly and Company, Loxo Oncology, Inc. | Prescription Medication | 2020-05-21 |
Loxo Oncology, Inc., Penn Pharmaceutical Services Ltd, Albemarle Corporation, Sharp Corporation | Prescription Medication | 2019-05-02 |
Loxo Oncology, Inc. | VITRAKVI | 2018-11-26 |
Loxo Oncology, Inc. | VITRAKVI | 2018-11-26 |
Loxo Oncology, Inc. | VITRAKVI | 2018-11-26 |
LOXO ONCOLOGY INC | 0000-00-00 00:00:00 |
SEC | 0001581720 | Loxo Oncology, Inc. of DELAWARE |